Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge

• Published in: Biochemistry (Moscow) Vol. 85; no. 5; pp. 553 - 566
• Main Authors: Boravleva, E. Y., Lunitsin, A. V., Kaplun, A. P., Bykova, N. V., Krasilnikov, I. V., Gambaryan, A. S.
• Format: Journal Article
• Language: English
• Published: Moscow Pleiades Publishing 01.05.2020; Springer; Springer Nature B.V
• Subjects: Adjuvants; Adjuvants, Immunologic - pharmacology; Animals; Antibodies; Avian flu; Biochemistry; Biomedical and Life Sciences; Biomedicine; Bioorganic Chemistry; Comparative analysis; Homology; Humans; Immune response; Immune system; Immunity; Immunization; Immunogenicity; Immunoglobulin G; Influenza; Influenza A Virus, H1N1 Subtype - immunology; Influenza A Virus, H1N1 Subtype - isolation & purification; Influenza A Virus, H5N1 Subtype - immunology; Influenza A Virus, H5N1 Subtype - isolation & purification; Influenza vaccines; Influenza Vaccines - pharmacology; Influenza, Human - immunology; Influenza, Human - prevention & control; Influenza, Human - virology; Levels; Life Sciences; Mice; Mice, Inbred BALB C; Microbiology; Observations; Patient outcomes; Vaccination; Vaccines; Vaccines, Inactivated - immunology; Virions; Viruses; Russia; influenza virus A; live and inactivated vaccine; adjuvants
• ISSN: 0006-2979; 1608-3040
• DOI: 10.1134/S0006297920050041

Inactivated (whole-virion, split, subunit, and adjuvanted) vaccines and live attenuated vaccine were tested in parallel to compare their immunogenicity and protective efficacy. Homologous and heterosubtypic protection against the challenge with influenza H5N1 and H1N1 viruses in a mouse model were studied. Single immunization with live or inactivated whole-virion H5N1 vaccine elicited a high level of serum antibodies and provided complete protection against the challenge with the lethal A/Chicken/Kurgan/3/05 (H5N1) virus, whereas application of a single dose of the split vaccine was much less effective. Adjuvants increased the antibody levels. Addition of the Iso-SANP adjuvant to the split vaccine led to a paradoxical outcome: it increased the antibody levels but reduced the protective effect of the vaccine. All tested adjuvants shifted the ratio between IgG1 and IgG2a antibodies. Immunization with any of the tested heterosubtypic live viruses provided partial protection against the H5N1 challenge and significantly reduced mouse mortality, while inactivated H1N1 vaccine offered no protection at all. More severe course of illness and earlier death were observed in mice after immunization with adjuvanted subunit vaccines followed by the challenge with the heterosubtypic virus compared to challenged unvaccinated animals.